TrialDiabetes care2023

Pharmacokinetics and Pharmacodynamics of a Novel U500 Insulin Aspart Formulation: A Randomized, Double-Blind, Crossover Study in People With Type 1 Diabetes.

Eva Svehlikova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.